Gut Inflammation (60 Capsules) (Stable BPC-157 Arginate, KPV, Larazotide)

Gut Inflammation (60 Capsules) — Targeted Gastrointestinal Integrity & Barrier Repair Complex

Gut Inflammation Capsules feature an advanced orally bioavailable research blend combining Stable BPC-157 Arginate, KPV (Lysine-Proline-Valine), and Larazotide (AT-1001). Precision-formulated into a 60-capsule delivery format, this potent triad is designed for investigators researching gastrointestinal mucosal healing, tight junction regulation, and inflammatory signaling pathways within the gut ecosystem.

• Purity & Precision Guaranteed: Synthesized to a baseline purity of $\ge 99\%$ verified by rigorous HPLC and Mass Spectrometry testing, keeping your laboratory assays consistent with strict standards on the Peptide Sciences Official platform.

• Synergistic Tri-Active Mechanism: Integrates gastric juice-stable BPC-157 Arginate for mucosal repair, KPV for downregulating pro-inflammatory NF-$\kappa$B pathways, and Larazotide as a tight junction regulator to study intestinal permeability (“leaky gut”) dynamics.

• Key Research Fields: Extensively utilized in gastroenterology and immunology models to evaluate inflammatory bowel conditions (IBD/IBS), tight junction occlusion, dysbiosis-induced inflammation, and epithelial tissue restoration kinetics.

• Encapsulated Oral Delivery: Designed to withstand standard enzymatic degradation in gastric environments, ensuring target-site biological activity across GI research models without complex reconstitution steps.

Research Compliance & Sourcing Notice: This product is sold strictly as a high-purity research chemical formulation. It is intended solely for laboratory, in vitro, or animal research applications and is not approved for human consumption, therapeutic, or diagnostic use. For verified, high-quality reference standards and compliant distribution channels, researchers rely on authorized supply pathways like Official Peptide Partners.